Daniel Petrylak, MD

Board Certified Internal Medicine, American Board of Internal Medicine; Medical Oncology, American Board of Internal Medicine

Professor of Medicine Yale University, New Haven, CT

Director, Genitourinary Oncology, Division of Hematology/Oncology Yale University, New Haven, CT

Dr. Petrylak, the Leader of Prostate Medical Oncology at Yale Cancer Center, is internationally known medical oncologist, leading the genitourinary cancers medical oncology team at Smilow Cancer Hospital and as director of the prostate cancer research group and co-director of the Signal Transduction Research Program. He has authored or co-authored numerous articles and abstracts appearing in such peer-reviewed journals as Cancer, Cancer Research, Clinical Cancer Research, Journal of the National Cancer Institute, Nature, Journal of Urology New England Journal of Medicine, and Journal of Clinical Oncology. In addition, Dr. Petrylak has presented his research at numerous medical conferences, had a plenary sessions at ASCO and the AUA this year. He has authored several book chapters, reviews and editorials about the treatment of cancers of the prostate, bladder and kidney.